Back to Search
Start Over
Blocking NAD(+)/CD38/cADPR/Ca(2+) pathway in sepsis prevents organ damage.
- Source :
-
The Journal of surgical research [J Surg Res] 2016 Apr; Vol. 201 (2), pp. 480-9. Date of Electronic Publication: 2015 Nov 25. - Publication Year :
- 2016
-
Abstract
- Background: Although the nicotinamide adenine dinucleotide (NAD(+))/CD38/cyclic ADP ribose (cADPR)/Ca(2+) signaling pathway has been shown to regulate intracellular calcium homeostasis and functions in multiple inflammatory processes, its role in sepsis remains unknown. The aim of this study was to determine whether the NAD(+)/CD38/cADPR/Ca(2+) signaling pathway is activated during sepsis and whether an inhibitor of this pathway, 8-Br-cADPR, protects the organs from sepsis-induced damage.<br />Materials and Methods: Male Sprague-Dawley rats were subjected to cecal ligation and puncture (CLP) or sham laparotomies. NAD(+), cADPR, CD38, and intracellular Ca(2+) levels were measured in the hearts, livers, and kidneys of septic rats at 0, 6, 12, 24, and 48 h after CLP surgery. Rats were also divided into sham, CLP, and CLP+8-Br-cADPR groups, and the hearts, livers, and kidneys were hematoxylin-eosin-stained and assayed for malondialdehyde and superoxide dismutase activities.<br />Results: NAD(+), cADPR, CD38, and intracellular Ca(2+) levels increased in the hearts, livers, and kidneys of septic rats as early as 6-24 h after CLP surgery. Treatment with 8-Br-cADPR inhibited sepsis-induced intracellular Ca(2+) mobilization, attenuated tissue injury, reduced malondialdehyde levels, and increased superoxide dismutase activity in septic rats.<br />Conclusions: The NAD(+)/CD38/cADPR/Ca(2+) signaling pathway was activated during sepsis in the CLP rat model. Blocking this pathway with 8-Br-cADPR protected hearts, livers, and kidneys from sepsis-induced damage.<br /> (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Subjects :
- ADP-ribosyl Cyclase metabolism
ADP-ribosyl Cyclase 1 metabolism
Animals
Calcium metabolism
Cyclic ADP-Ribose metabolism
Cyclic ADP-Ribose pharmacology
Cyclic ADP-Ribose therapeutic use
Disease Models, Animal
Drug Evaluation, Preclinical
Male
Malondialdehyde metabolism
Membrane Glycoproteins metabolism
Multiple Organ Failure etiology
NAD metabolism
Random Allocation
Rats, Sprague-Dawley
Sepsis metabolism
Superoxide Dismutase metabolism
Calcium Signaling drug effects
Cyclic ADP-Ribose analogs & derivatives
Multiple Organ Failure prevention & control
Sepsis complications
Subjects
Details
- Language :
- English
- ISSN :
- 1095-8673
- Volume :
- 201
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- The Journal of surgical research
- Publication Type :
- Academic Journal
- Accession number :
- 27020835
- Full Text :
- https://doi.org/10.1016/j.jss.2015.11.029